Re: Management of Peyronie's Disease with Collagenase Clostridium Histolyticum in the Acute Phase

被引：0

作者：

El-Khatib, F. M. ^{[1
]}

Towe, M. ^{[1
]}

Yafi, F. A. ^{[1
]}

机构：

[1] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA

来源：

JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：289 / 289

页数：1

共 50 条

[41] INTRALESIONAL INJECTION OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE MANAGEMENT OF PEYRONIE'S DISEASE WITH INDENTATION OR HOURGLASS DEFORMITY
Osman, Mahdi
Towe, Maxwell
EL-Khatib, Farouk M.
Huynh, Linda
Yafi, Faysal A.
JOURNAL OF UROLOGY, 2019, 201 (04): : E952 - E953
[42] Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial
Trost, Landon
JOURNAL OF UROLOGY, 2024, 211 (05): : 710 - 712
[43] Letter: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial
Jin, Dachun
Li, Yanfeng
JOURNAL OF UROLOGY, 2023, 211 (01):
[44] Letter: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial
Desouky, Elsayed
Levine, Laurence A.
JOURNAL OF UROLOGY, 2024, 211 (05): : 708 - 709
[45] Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial Reply
Barham, David W.
Yaf, Faysal A.
Roth, Bradley J.
Bajic, Petar
JOURNAL OF UROLOGY, 2023, 210 (05): : 802 - 802
[46] Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie's disease
Aliperti, Louis A.
Mehta, Akanksha
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (01) : 114 - 115
[47] Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
Masterson, Thomas
Patel, Premal
Ramasamy, Ranjith
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2020, 32 (02) : 251 - 252
[48] Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis
Hoang Minh Tue Nguyen
Yousif, Ayad
Chung, Amanda
Virasoro, Ramon
Tapscott, Ashley
Ziegelmann, Matthew
Trost, Landon
Gelbard, Martin
Hellstrom, Wayne J. G.
UROLOGY, 2020, 145 : 147 - 151
[49] Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
Thomas Masterson
Premal Patel
Ranjith Ramasamy
International Journal of Impotence Research, 2020, 32 : 251 - 252
[50] Re: Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms
Morey, Allen F.
JOURNAL OF UROLOGY, 2017, 197 (03): : 752 - 752

← 1 2 3 4 5 →